Armata Pharmaceuticals (ARMP) Other Operating Expenses (2014 - 2026)
Armata Pharmaceuticals (ARMP) posted Other Operating Expenses of -$2.0 million for Q1 2026, down 163.52% sequentially from $3.2 million in Q4 2025, and down 8.05% YoY from -$2.2 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Other Operating Expenses (2014 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Other Operating Expenses for 8 years, with the latest figure at -$2.0 million in Q1 2026.
- Quarterly Other Operating Expenses fell 8.05% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (up 71.38% YoY) and the FY2025 annual result came in at -$2.1 million, up 74.54% from the prior year.
- Other Operating Expenses declined to -$2.0 million in Q1 2026 per ARMP's latest filing, from $3.2 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $3.2 million in Q4 2025 and troughed at -$2.2 million in Q1 2024.
- A 3-year average of -$1.4 million and a median of -$2.0 million in 2025 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses surged 245.43% in 2025, then fell 8.05% in 2026.
- Over 3 years, Other Operating Expenses stood at -$2.2 million in 2024, then soared by 245.43% to $3.2 million in 2025, then plunged by 163.52% to -$2.0 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$2.0 million, $3.2 million, and -$2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.19 Mn |
| Mar 31, 2026 | -2.00 Mn |
| Dec 31, 2025 | 3.15 Mn |
| Sep 30, 2025 | -1.97 Mn |
| Jun 30, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -1.87 Mn |
| Mar 31, 2024 | -2.24 Mn |
| Dec 31, 2019 | 1.14 Mn |
| Mar 31, 2019 | 165,000.00 |
| Sep 30, 2017 | -829,000.00 |
| Jun 30, 2017 | 5.80 Mn |
| Dec 31, 2016 | 4.80 Mn |
| Sep 30, 2016 | 1.61 Mn |
| Sep 30, 2015 | -289,000.00 |
| Sep 30, 2014 | 1.84 Mn |